Brief: Myriad Genetics Q3 Operating Income USD -60.1 Million
06/11/2023 21:05
Nov 06 (Reuters) - Myriad Genetics Q3 gross margin 70%. * Q3 adjusted operating expenses USD 137.3 million * Q3 operating expenses USD 194.4 million * Q3 adjusted operating income USD -2.2 million
Recent news on Myriad Genetics
See all newsUS STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple